Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor

Abstract Despite the concern of within-tumor genetic diversity, this diversity is in fact limited by the kinship among cells in the tumor. Indeed, genomic studies have amply supported the ‘Nowell dogma’ whereby cells of the same tumor descend from a single progenitor cell. In parallel, genomic data also suggest that the diversity could be >10-fold larger if tumor cells are of multiple origins. We develop an evolutionary hypothesis that a single tumor may often harbor multiple cell clones of independent origins, but only one would be large enough to be detected. To test the hypothesis, we search for independent tumors within a larger one (or tumors-in-tumor). Very high density sampling was done on two cases of colon tumors. Case 1 indeed has 13 independent clones of disparate sizes, many having heavy mutation burdens and potentially highly tumorigenic. In Case 2, despite a very intensive search, only two small independent clones could be found. The two cases show very similar movements and metastasis of the dominant clone. Cells initially move actively in the expanding tumor but become nearly immobile in late stages. In conclusion, tumors-in-tumor are plausible but could be very demanding to find. Despite their small sizes, they can enhance the within-tumor diversity by orders of magnitude. Such increases may contribute to the missing genetic diversity associated with the resistance to cancer therapy.

[1]  J. Fowler,et al.  Mutant clones in normal epithelium outcompete and eliminate emerging tumours , 2021, Nature.

[2]  S. Ogawa,et al.  Clonal expansion in non-cancer tissues , 2021, Nature Reviews Cancer.

[3]  S. Loi,et al.  Intratumoral heterogeneity in cancer progression and response to immunotherapy , 2021, Nature Medicine.

[4]  L. Galluzzi,et al.  Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.

[5]  Xin Luo,et al.  Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease , 2019, Cell.

[6]  Nicolai J. Birkbak,et al.  Neoantigen-directed immune escape in lung cancer evolution , 2019, Nature.

[7]  J. B. Jensen,et al.  Mutational analysis of field cancerization in bladder cancer , 2019, bioRxiv.

[8]  M. Stratton,et al.  The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.

[9]  Peter J. Campbell,et al.  Somatic mutant clones colonize the human esophagus with age , 2018, Science.

[10]  Thomas O. McDonald,et al.  Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution , 2018, Nature Genetics.

[11]  Marc J. Williams,et al.  Reply to ‘Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution’ , 2018, Nature Genetics.

[12]  S. Luo,et al.  High prevalence of focal and multi-focal somatic genetic variants in the human brain , 2018, Nature Communications.

[13]  Xionglei He,et al.  On the low reproducibility of cancer studies. , 2018, National science review.

[14]  Ville Mustonen,et al.  The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.

[15]  Wyeth W. Wasserman,et al.  Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer , 2018, Cell.

[16]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[17]  Marc J. Williams,et al.  Reply: Is the evolution of tumors Darwinian or non-Darwinian? , 2018 .

[18]  T. Graham,et al.  An evolutionary perspective on field cancerization , 2017, Nature Reviews Cancer.

[19]  Xuemei Lu,et al.  Is the evolution in tumors Darwinian or non-Darwinian? , 2018 .

[20]  Ying Shen,et al.  Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer , 2017, Nature Communications.

[21]  P. Lønning,et al.  Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.

[22]  Adam D. DePriest,et al.  Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. , 2017, European urology.

[23]  Xuemei Lu,et al.  Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.

[24]  R. Hudson,et al.  Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics , 2015, bioRxiv.

[25]  A. Palumbo,et al.  Genetic instability in the tumor microenvironment: a new look at an old neighbor , 2015, Molecular Cancer.

[26]  C. Curtis,et al.  A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.

[27]  Andrew Menzies,et al.  Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue , 2015, Nature Genetics.

[28]  Alexander G. Fletcher,et al.  Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon , 2014, Cell reports.

[29]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[30]  D. Shibata,et al.  Direct Measurements of Human Colon Crypt Stem Cell Niche Genetic Fidelity: The Role of Chance in Non-Darwinian Mutation Selection , 2013, Front. Oncol..

[31]  L. Pusztai,et al.  Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.

[32]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[33]  R. Minchin,et al.  Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.

[34]  T. Graham,et al.  Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. , 2012, Gastroenterology.

[35]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[36]  Hans Clevers,et al.  Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells , 2010, Cell.

[37]  S. Srivastava,et al.  Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer , 2008, Modern Pathology.

[38]  M. Weiser,et al.  An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[40]  John Cairns,et al.  Mutation selection and the natural history of cancer , 1975, Nature.